From his latest update on his LIC that holds Mesoblast, TEK. Nothing new, but some might find it relevant:
"A global biotech leader, Mesoblast has a range of patented stem cell treatmentsfor several intractable diseases including acute graft versus host disease,chronic heart failure and chronic back pain. This year and next will bepivotal for MSB as it seeks to obtain FDA approval for its first product salesin the USA.
We have been pushing the company to make changes to prepare for thecommercialisation phase. We welcome the recently announced appointment of anew US-based Chairman, Mr Joseph Swedish, with very strong US health careexperience and credentials to oversee this next crucial stage in the company’sdevelopment.
After many years we believe MSB may finally be on the cusp of becoming anAustralian-based global biotech success story in the tradition of CSL,Cochlear, Resmed and all too few others."
https://hotcopper.com.au/threads/ann-chairmans-update-april-2019.4697369/
Waislitz on MSB
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.00 |
Change
0.010(1.01%) |
Mkt cap ! $1.141B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.01 | 94.3¢ | $8.618M | 8.821M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 43508 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.01 | 34138 | 2 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |